New drug cocktail aims to tackle tough sarcomas in young patients
Disease control
Recruiting now
This study tests a new drug called PEEL-224 combined with two standard chemotherapy drugs (vincristine and temozolomide) in adolescents and young adults whose sarcomas have returned or not responded to treatment. The trial has two phases: first, finding the safest dose, then chec…
Phase: PHASE1, PHASE2 • Sponsor: David S Shulman, MD • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC